Lumigan - Drug Details
๐Ÿ“Š Estimates Lumigan Dialyzability By Different_Modalities

Lumigan

Complete Drug Information

Drug Name
Lumigan
Trade Names
Lumigan
Pregnancy Category
AU: B3
Bioavailability
Low
Routes of Administration
eye drops
Protein Binding
88%%
Elimination
45 min after intravenous application
Excretion
67% Kidney, 25% fecal
Formula
C25H37NO4
Molar Mass
415.574
Onset of Action
4 hrs
Duration of Action
โ‰ฅ 24 hrs
Volume of Distribution
C25H37NO4

๐Ÿคฐ Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.